Literature DB >> 947739

Carbenoxolone sodium: its role in ulcer healing.

M J Langman.   

Abstract

In summary, carbenoxolone is a useful drug in accelerating short-term ulcer healing during ambulatory treatments. Provided treatment is responsibly controlled the adverse effects should not present frequent or severe problems; however, there is a clear need for an analogue which is substantially side-effect free.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 947739     DOI： 10.2165/00003495-197611040-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


  12 in total

1.  Triterpenoid liquorice compound in gastric and duodenal ulcer.

Authors:  R DOLL; I D HILL
Journal:  Lancet       Date:  1962-12-01       Impact factor: 79.321

2.  Inhibition of peptic activity in man by carbenoxolyne sodium.

Authors:  A Berstad
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

3.  Complications of carbenoxolone therapy.

Authors:  G J Davies; J Rhodes; B J Calcraft
Journal:  Br Med J       Date:  1974-08-10

Review 4.  In 'defence' of the gastric mucosa.

Authors:  M Lipkin
Journal:  Gut       Date:  1971-07       Impact factor: 23.059

5.  A controlled trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer.

Authors:  R D Montgomery; I H Lawrence; D J Manton; K Mendl; P Rowe
Journal:  Gut       Date:  1968-12       Impact factor: 23.059

6.  Factors influencing the healing rate of chronic gastric ulcer.

Authors:  R P Herrmann; D W Piper
Journal:  Am J Dig Dis       Date:  1973-01

7.  The Veterans Administration Cooperative Study on Gastric Ulcer. 3. Site and size of the ulcer as determinants of outcome.

Authors:  D C Sun; S J Stempien
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

8.  Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone.

Authors:  R Doll; M J Langman; H H Shawdon
Journal:  Gut       Date:  1968-02       Impact factor: 23.059

9.  Clinical trial of a new carbenoxolone analogue (BX24), zinc sulphate, and vitamin A in the treatment of gastric ulcer.

Authors:  P M Fraser; R Doll; M J Langman; J J Misiewicz; H H Shawdon
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

10.  Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trial.

Authors:  M J Langman; D R Knapp; E J Wakley
Journal:  Br Med J       Date:  1973-07-14
View more
  1 in total

1.  Effect of ulcer healing on the prognosis of chronic gastric uler. Four-year follow-up.

Authors:  D W Piper; J Shinners; M Greig; J Thomas; S L Waller
Journal:  Gut       Date:  1978-05       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.